Emerging ferroptosis-immunotherapy strategies,integrating functionalized nanoplatforms with ferroptosis-inducing agents and immunomodulatory therapeutics,demonstrate significant potential in managing primary,recurrent...Emerging ferroptosis-immunotherapy strategies,integrating functionalized nanoplatforms with ferroptosis-inducing agents and immunomodulatory therapeutics,demonstrate significant potential in managing primary,recurrent,and metastatic malignancies.Mechanistically,ferroptosis induction not only directly eliminates tumor cells but also promotes immunogenic cell death(ICD),eliciting damage-associated molecular patterns(DAMPs)release to activate partial antitumor immunity.However,standalone ferroptosis therapy fails to initiate robust systemic antitumor immune responses due to inherent limitations:low tumor immunogenicity,immunosuppressive microenvironment constraints,and tumor microenvironment(TME)-associated physiological barriers(e.g.,hypoxia,dense extracellular matrix).To address these challenges,synergistic approaches have been developed to enhance immune cell infiltration and reestablish immunosurveillance,encompassing(1)direct amplification of antitumor immunity,(2)disruption of immunosuppressive tumor niches,and(3)biophysical hallmark remodeling in TME.Rational nanocarrier design has emerged as a critical enabler for overcoming biological delivery barriers and optimizing therapeutic efficacy.Unlike prior studies solely addressing ferroptosis or nanotechnology in tumor therapy,this work first systematically outlines the synergistic potential of nanoparticles in combined ferroptosis-immunotherapy strategies.It advances multidimensional nanoplatform design principles for material selection,structural configuration,physicochemical modulation,multifunctional integration,and artificial intelligence-enabled design,providing a scientific basis for efficacy optimization.Moreover,it examines translational challenges of ferroptosis-immunotherapy nanoplatforms across preclinical and clinical stages,proposing actionable solutions while envisioning future onco-immunotherapy directions.Collectively,it provides systematic insights into advanced nanomaterial design principles and therapeutic optimization strategies,offering a roadmap for accelerating clinical translation in onco-immunotherapy research.展开更多
Colorectal cancer remains one of the leading causes of morbidity and mortality worldwide.Despite notable advances in early detection and therapeutic strategies,the molecular mechanisms underlying tumor survival,chemot...Colorectal cancer remains one of the leading causes of morbidity and mortality worldwide.Despite notable advances in early detection and therapeutic strategies,the molecular mechanisms underlying tumor survival,chemotherapy resistance,and metastasis are not yet fully understood.MicroRNAs(miRNAs)have emerged as pivotal regulators of cancer development,as they modulate gene expression and orchestrate key signaling pathways.However,the epigenetic mechanisms that control miRNA expression and their downstream gene targets remain largely unclear.In this review,we highlight the critical role of the colorectal cancer microenvironment in influencing miRNA expression and discuss how this regulation contributes to tumorigenesis.A better understanding of these processes may lead to the identification of novel therapeutic targets and strategies to prevent recurrence.展开更多
Colorectal cancer(CRC)is ranked as the third most common tumor globally,representing approximately 10%of all cancer cases,and is the second primary cause of cancer-associated mortality.Existing therapeutic approaches ...Colorectal cancer(CRC)is ranked as the third most common tumor globally,representing approximately 10%of all cancer cases,and is the second primary cause of cancer-associated mortality.Existing therapeutic approaches demonstrate limited efficacy against CRC,partially due to the immunosuppressive tumor microenvironment(TME).In recent years,substantial evidence indicates that dysbiosis of the gut microbiota and its metabolic products is closely associated with the initiation,progression,and prognostic outcomes of CRC.In this minireview,we systematically elaborate on how these microbes and their metabolites directly impair intestinal epithelial integrity,activate cancer-associated fibroblasts,remodel tumor vasculature,and critically,sculpt an immunosuppressive landscape by modulating T cells,dendritic cells,and tumor-associated macrophages.We highlight the translational potential of targeting the gut microbiota,including fecal microbiota transplantation,probiotics,and engineered microbial systems,to reprogram the TME and overcome resistance to immunotherapy and chemotherapy.A deeper understanding of the microbiota-TME axis is essential for developing novel diagnostic and therapeutic paradigms for CRC.展开更多
BACKGROUND In recent years,numerous reports have been published regarding the relationship between the gut microbiota and the tumor immune microenvironment(TIME).However,to date,no systematic study has been conducted ...BACKGROUND In recent years,numerous reports have been published regarding the relationship between the gut microbiota and the tumor immune microenvironment(TIME).However,to date,no systematic study has been conducted on the relationship between gut microbiota and the TIME using bibliometric methods.AIM To describe the current global research status on the correlation between gut microbiota and the TIME,and to identify the most influential countries,research institutions,researchers,and research hotspots related to this topic.METHODS We searched for all literature related to gut microbiota and TIME published from January 1,2014,to May 28,2024,in the Web of Science Core Collection database.We then conducted a bibliometric analysis and created visual maps of the published literature on countries,institutions,authors,keywords,references,etc.,using CiteSpace(6.2R6),VOSviewer(1.6.20),and bibliometrics(based on R 4.3.2).RESULTS In total,491 documents were included,with a rapid increase in the number of publications starting in 2019.The country with the highest number of publications was China,followed by the United States.Germany has the highest number of citations in literature.From a centrality perspective,the United States has the highest influence in this field.The institutions with the highest number of publications were Shanghai Jiao Tong University and Zhejiang University.However,the institution with the most citations was the United States National Cancer Institute.Among authors,Professor Giorgio Trinchieri from the National Institutes of Health has the most local impact in this field.The most cited author was Fan XZ.The results of journal publications showed that the top three journals with the highest number of published papers were Frontiers in Immunology,Cancers,and Frontiers in Oncology.The three most frequently used keywords were gut microbiota,tumor microenvironment,and immunotherapy.CONCLUSION This study systematically elaborates on the research progress related to gut microbiota and TIME over the past decade.Research results indicate that the number of publications has rapidly increased since 2019,with research hotspots including“gut microbiota”,“tumor microenvironment”and“immunotherapy”.Exploring the effects of specific gut microbiota or derived metabolites on the behavior of immune cells in the TIME,regulating the secretion of immune molecules,and influencing immunotherapy are research hotspots and future research directions.展开更多
Approximately half of all cancers have p53 inactivating mutations,in addition to which most malignancies inactivate the p53 pathway by increasing p53 inhibitors,decreasing p53 activators,or inactivating p53 downstream...Approximately half of all cancers have p53 inactivating mutations,in addition to which most malignancies inactivate the p53 pathway by increasing p53 inhibitors,decreasing p53 activators,or inactivating p53 downstream targets.A growing number of researches have demonstrated that p53 can influence tumor progression through the tumor microenvironment(TME).TME is involved in the process of tumor development and metastasis and affects the clinical prognosis of patients.p53 participates in host immunity and engages in the immune landscape of the TME,but the specific mechanisms remain to be investigated.This review briefly explores the interactions between different states of p53 and TME components and their mechanisms,as well as their effects on tumor progression.To understand the progress of drug development and clinical studies related to p53 and tumor microenvironment.展开更多
Ferroptosis is a novel form of cell death driven by oxidative damage,and is implicated in various pathological conditions,including neurodegenerative diseases,retinal damage,and ischemia-reperfusion injury of organs.I...Ferroptosis is a novel form of cell death driven by oxidative damage,and is implicated in various pathological conditions,including neurodegenerative diseases,retinal damage,and ischemia-reperfusion injury of organs.Inhibiting ferroptosis has shown great promise as a therapeutic strategy for these diseases,underscoring the urgent need to develop effective ferroptosis inhibitors.Although Ferrostatin-1(Fer-1)is a potent ferroptosis inhibitor,its susceptibility to oxidation and metabolic inactivation limits its clinical utility.In this study,the accumulation of peroxides and the resulting oxidative damage in the cellular microenvironment during ferroptosis were utilized to design Ferrostatin-1 prodrugs with reactive oxygen species-responsive features.This approach led to the development of a series of ferroptosis inhibitors that were capable of recognizing oxidative damage in diseased areas,allowing for targeted release and improved stability.The novel compounds demonstrated significant inhibitory effects and selectivity against RSL-3-induced ferroptosis in HK-2 cells,with compound a1 exhibiting an EC50 of 15.4�0.7μM,outperforming Fer-1.These compounds effectively identify the oxidative microenvironment associated with ferroptosis,enabling the targeted release of Fer-1,which prevents lipid peroxide accumulation and inhibits ferroptosis.This strategy holds promise for treating diseases related to ferroptosis,offering a targeted and intelligent therapeutic approach.展开更多
In the past decade,immunotherapies targeting cytotoxic T-lymphocyte antigen-4(CTLA-4),programmed cell death 1(PD-1),and PD-1 ligand(PD-L1)have been approved for solid tumors.However,some patients demonstrate suboptima...In the past decade,immunotherapies targeting cytotoxic T-lymphocyte antigen-4(CTLA-4),programmed cell death 1(PD-1),and PD-1 ligand(PD-L1)have been approved for solid tumors.However,some patients demonstrate suboptimal clinical outcomes due to resistance.The tumor microenvironment(TME)significantly affects the efficiency of immunotherapy by mediating interactions between tumor and non-tumor cells,including dendritic cells,T cells,B cells,macrophages,neutrophils,NK cells,and myeloid-derived suppressor cells(MDSCs).These non-tumor cells often exhibit two phenotypes with altered functions,and tumor cells drives their transition towards tumor promotion through tumor-education.Tumor-educated cells(TECs)are cells influenced by tumor cells,which acquire immune-suppressive phenotypes and promote tumor progression through resistance to anticancer therapies.These cells undergo modifications in response to signals from the tumor,which can influence their roles in tumor progression.Their dynamic interactions with tumor cells contribute to the reshaping of the TME,facilitating cancer growth and immune modulation.This review summarizes research on TECs in TME,explores mechanisms related to tumor education,and discusses their role in tumor progression and immunotherapy resistance.Additionally,potential therapeutic approaches targeting these cells are also reviewed,which may complement current treatment strategies.展开更多
Hepatocellular carcinoma(HCC)is a highly aggressive malignancy,largely driven by an immunosuppres-sive tumor microenvironment(TME)that facilitates tumor growth,immune escape,and resistance to therapy.Although immunoth...Hepatocellular carcinoma(HCC)is a highly aggressive malignancy,largely driven by an immunosuppres-sive tumor microenvironment(TME)that facilitates tumor growth,immune escape,and resistance to therapy.Although immunotherapy—particularly immune checkpoint inhibitors(ICIs)—has transformed the therapeutic landscape by restoring T cell-mediated anti-tumor responses,their clinical benefit as monotherapy remains suboptimal.This limitation is primarily attributed to immunosuppressive components within the TME,including tumor-associated macrophages,regulatory T cells(Tregs),and myeloid-derived suppressor cells(MDSCs).To address these challenges,combination strategies have been explored,such as dual checkpoint blockade targeting programmed cell death protein 1(PD-1),programmed death-ligand 1(PD-L1),and cytotoxic T-lymphocyte-associated antigen 4(CTLA-4),as well as synergistic use of ICIs with anti-angiogenic agents or TME-targeted interventions.These approaches have shown encouraging potential in enhancing immune efficacy.This review outlines the complex crosstalk between the TME and immunotherapeutic responses in HCC,emphasizing how combination regimens may overcome immune resistance.Furthermore,we discuss the remaining hurdles,including therapeutic resistance and immune-related adverse events,and propose future directions involving TME-associated biomarkers and individualized treatment strategies to improve patient outcomes.展开更多
In this article,we comment on the work published by Huang et al,which explores the mechanisms by which Calculus bovis(CB)modulates the liver cancer immune microenvironment via the Wnt/β-catenin signalling pathway.The...In this article,we comment on the work published by Huang et al,which explores the mechanisms by which Calculus bovis(CB)modulates the liver cancer immune microenvironment via the Wnt/β-catenin signalling pathway.The study demon-strates that active components in CB effectively inhibit the activation of the Wnt/β-catenin pathway,significantly reducing the polarization of M2 tumor-associated macrophages.Both in vivo and in vitro experiments have validated the anti-tumour effects of CB,revealing its complex mechanisms of action through the modulation of immune cell functions within the tumour microenvironment.This article highlights CB’s therapeutic potential in liver cancer treatment and calls for further investigations into its mechanisms and clinical applications to develop safer,more effective options for patients.The study also revealed that key com-ponents of CB,such as bilirubin and bile acids,inhibit tumour cell proliferation and promote apoptosis through multiple pathways.Future research should explore the mechanisms of action of CB and its potential integration with existing treatments to improve the therapeutic outcomes of liver cancer patients.With multidisciplinary collaboration and advanced research,CB could become a key component of comprehensive liver cancer treatment,offering new hope for patients.展开更多
Colorectal cancer(CRC)considerably affects global health,and its progression is intricately tied to interactions within the tumormicroenvironment.This review focuses on the intricate crosstalk between metabolic reprog...Colorectal cancer(CRC)considerably affects global health,and its progression is intricately tied to interactions within the tumormicroenvironment.This review focuses on the intricate crosstalk between metabolic reprogramming in CRC cells and the tumor immune microenvironment(TIME),thereby emphasizing the dual functionality of metabolic pathways in tumor growth and immune regulation.Furthermore,the review delves into key metabolic changes,including alterations in glucose,lipid,iron,and ammonia metabolism,and their profound effects on the immune landscape of CRC.Enhanced glycolysis and lipid metabolism facilitate tumor survival and proliferation,while establishing an immunosuppressive TIME that hinders effective immune responses.Moreover,the roles of iron and ammonia metabolism in immune evasion and tumor progression were explored,and these metabolic pathways presented as promising targets to improve CRC therapy.By conducting a comprehensive analysis of recent studies,this review provides insights into potential therapeutic targets within these metabolic interactions,with the aim of enhancing the efficacy of existing treatments and devising novel strategies for combating CRC.展开更多
The presence of impurities in phosphogypsum has long impeded its effective utilization,highlighting the need for energy-efficient and sustainable purification methods.This study proposes a novel purification strategy ...The presence of impurities in phosphogypsum has long impeded its effective utilization,highlighting the need for energy-efficient and sustainable purification methods.This study proposes a novel purification strategy that synergistically combines pH regulation and micelle-assisted treatment to create an optimized microenvironment for impurity removal.Under mechanical grinding conditions,this approach enhances the rheological properties of the phosphogypsumslurries and facilitates the dissolution and removal of impurity ions.Experimental results demonstrate that the synergistic method achieves a remarkable 64.01%increase in whiteness while significantly reducing soluble phosphorus and fluoride content in a single-step process.This technique not only achieves high purification efficiency but also offers a practical pathway for the high-value utilization of phosphogypsum.These findings suggest that this method has substantial potential for enhancing sustainable resource management and enabling broader industrial applications of purified phosphogypsum.展开更多
The landscape of tumor microenvironment(TME)research has un-dergone rapid transformation over the past decade.1,2 As we deepen our understanding of the TME’s role in cancer progression,immune response modulation,and ...The landscape of tumor microenvironment(TME)research has un-dergone rapid transformation over the past decade.1,2 As we deepen our understanding of the TME’s role in cancer progression,immune response modulation,and therapeutic efficacy,this special issue,“Tumor Microen-vironment and Immunotherapy:From Bench to Bedside,”brings forth the latest breakthroughs in these domains.It highlights the interplay be-tween the TME,immune system dynamics,and cancer therapies,with a particular emphasis on precision medicine and the development of targeted treatments.展开更多
Therapy-induced modulation of the tumor microenvironment(TME)to overcome the immunosuppressive TME is considered to be a chance for cancer treatment.Herein,we prepared near-infrared absorbing aza-BODIPY PhEt-azaBDP wi...Therapy-induced modulation of the tumor microenvironment(TME)to overcome the immunosuppressive TME is considered to be a chance for cancer treatment.Herein,we prepared near-infrared absorbing aza-BODIPY PhEt-azaBDP with 1-phenylethyl group at 1,7-sites,a type I photodynamic-photothermal therapy(PDT-PTT)agent.Self-assembly PhEt-azaBDP nanoparticles(NPs)can provide combined phototherapeutic effects under light irradiation and simultaneously induce inflammatory TME,by monitoring tumorassociated macrophages(TAMs)repolarization.Utilizing cluster of differentiation 86(CD86)and CD163 as the M1-type marker and M2-type marker respectively,PhEt-azaBDP NPs resulted in the increasement of the expression of CD86 and the decreasement of the expression of CD163 in TAMs under near-infrared(NIR)light irradiation,promoting TAMs to switch from M2-phenotype to M1-phenotype.Inflammatory cytokines,interleukin-1β(IL-1β)and tumor necrosis factor-α(TNF-α),could be the key cytokine involved in the phototherapy-induced TME reprogramming.PhEt-azaBDP NPs could be a potential theranostic scaffold for the simultaneous induction and detection of TME reprogramming triggered by phototherapy.展开更多
Electrocatalytic CO_(2)reduction(CO_(2)RR)is spurring intensive research interest,where many attentions have been paid to catalyst design and mechanism study.Electrode near-surface microenvironment matters fundamental...Electrocatalytic CO_(2)reduction(CO_(2)RR)is spurring intensive research interest,where many attentions have been paid to catalyst design and mechanism study.Electrode near-surface microenvironment matters fundamentally for reactant mass transfer,water molecule interference,catalyst exposure,and others,yet it has been rarely investigated.In the latest issue of Angew.Chem.Int.Ed.,Han,Kang and coauthors reported a method to regulate the microenvironment on the catalyst surface by adding polyethylene glycol,which remarkably improves the yield of multicarbon products.This strategy of controlling multiple proton-electron coupling processes through molecular chemistry-driven microenvironmental regulation is thought to inspire new idea for addressing the low efficiency challenge of CO_(2)RR.展开更多
Sorafenib(Sora)not only has an inhibitory effect on angiogenesis via indirectly inhibiting tumor growth through antiangiogenesis,but also can inactivate the glutathione peroxidase 4(GPX4)to induce ferroptosis.Nonethel...Sorafenib(Sora)not only has an inhibitory effect on angiogenesis via indirectly inhibiting tumor growth through antiangiogenesis,but also can inactivate the glutathione peroxidase 4(GPX4)to induce ferroptosis.Nonetheless,the therapeutic efficacy is hampered by a plethora of factors,including low bioavailability and tumor microenvironment(TME).Of particular note is the hypoxic and reductive TME,which acts as a significant impediment and poses formidable challenges to attain the most optimal treatment outcomes.Herein,we developed a novel therapeutic platform based on Sora-loaded mesoporous ferromanganese nanoparticles(PMFNs@Sora).PMFNs mimics both catalase and GPX activities.The self-sustained catalase activity enables continuous decomposition of hydrogen peroxide to generate oxygen,which alleviates hypoxia microenvironment.The GPX activity simultaneously amplifies the therapeutic efficacy of Sora.The as-synthesized PMFNs@Sora demonstrates significantly enhanced antitumor effect in vitro through apoptosis-ferroptosis,revealed by Western blot.Furthermore,PMFNs@Sora also showed effective tumor growth inhibition in vivo.This multifunctional nanoplatform offers a promising strategy for modulating the TME and enhancing cancer treatment in clinical application.展开更多
Tumor-associated neutrophils(TANs)exhibit highly func-tional heterogeneity across cancers.Although TANs pro-mote inflammatory responses and contribute to tumor clearance,they frequently undergo context-dependent repro...Tumor-associated neutrophils(TANs)exhibit highly func-tional heterogeneity across cancers.Although TANs pro-mote inflammatory responses and contribute to tumor clearance,they frequently undergo context-dependent reprogramming within the tumor microenvironment(TME)into highly immunosuppressive phenotypes that facilitate cancer dissemination and immunotherapy resist-ance1,2.We contend that an underappreciated,upstream determinant of this divergence is the maturation stage of TANs3,4.The developmental stage of TANs determines the migration patterns and constrains the functional capacity,and the developmental stage also constrains the extent of TME-driven re-education,together shaping pro-or anti-tu-mor outcomes3-5.In this Perspective,we place maturation at the core of TAN biology and discuss current definitions for TAN developmental stages and the measurable mark-ers that researchers and clinicians can use(Figure 1).In addition,spatial and temporal transitions in TAN matu-ration stages and the factors that govern these transitions are elucidated.We explain how maturation status shapes TAN function and articulate the key differences between mouse and human TAN maturation systems to highlight the value of human immune system(HIS)mouse models.Based on this framework,functional biomarkers and signa-tures of TAN maturation are introduced and we show how to embed them into patient stratification and longitudinal monitoring.Finally,we outline immunotherapy strategies targeting TAN maturation,selecting interventions guided by maturation markers to reinforce treatment benefits for cancer patients.展开更多
Severe tissue defects present formidable challenges to human health,persisting as major contributors to mortality rates.The complex pathological microenvironment,particularly the disrupted immune landscape within thes...Severe tissue defects present formidable challenges to human health,persisting as major contributors to mortality rates.The complex pathological microenvironment,particularly the disrupted immune landscape within these defects,poses substantial hurdles to existing tissue regeneration strategies.However,the emergence of nanobiotechnology has opened a new direction in immunomodulatory nanomedicine,providing encouraging prospects for tissue regeneration and restoration.This review aims to gather recent advances in immunomodulatory nanomedicine to foster tissue regeneration.We begin by elucidating the distinctive features of the local immune microenvironment within defective tissues and its crucial role in tissue regeneration.Subsequently,we explore the design and functional properties of immunomodulatory nanosystems.Finally,we address the challenges and prospects of clinical translation in nanomedicine development,aiming to propose a potent approach to enhance tissue regeneration through synergistic immune modulation and nanomedicine integration.展开更多
Objective:A highly aggressive and lethal malignancy,characterized by its heterogeneity,lung adenocarcinoma(LUAD)presents significant challenges in prognosis and treatment.Disulfidptosis,a newly identified form of regu...Objective:A highly aggressive and lethal malignancy,characterized by its heterogeneity,lung adenocarcinoma(LUAD)presents significant challenges in prognosis and treatment.Disulfidptosis,a newly identified form of regulated cell death,offers novel insights into cancer progression,yet its role in LUAD remains poorly understood.Methods:We identified disulfidptosis-related genes(DRGs)from prior studies and analyzed their interactions and functional enrichment.Molecular subtypes were identified through consensus clustering based on DRG expression,and a prognostic DRG signature was developed using multivariate Cox regression analysis.A nomogram integrating clinical variables was developed to predict survival.Comprehensive analyses,including single-cell RNA sequencing,immune infiltration,and drug sensitivity,were validated using clinical specimens,LUAD cell lines,Western blotting(WB)and immunohistochemistry(IHC).Results:A total of 16 DRGs were identified,classifying LUAD patients into three distinct subtypes with differential survival and immune profiles.A 4-gene signature(GYS1,NDUFA11,NDUFB10,SLC7A11)was used to build a risk score model,demonstrating robust prognostic accuracy.A nomogram combining this signature with clinical features reliably predicted 1-,3-,and 5-year survival.The signature correlated with immune cell infiltration,with single-cell analysis revealing DRG enrichment in myeloid cells.Notably,SLC7A11 and GYS1 were positively associated with chemotherapeutic drug sensitivity.Validation through reverse transcription quantitative polymerase chain reaction(RT-qPCR),WB and IHC confirmed upregulated DRG expression in LUAD tissues and cell lines.Conclusions:This research highlights the essential role of DRGs in modulating the tumor microenvironment,influencing therapeutic response,and determining the prognosis of LUAD.The risk model and nomogram,derived from DRG expression,offer robust tools for survival prediction and personalized treatment stratification,facilitating the development of disulfidptosis-targeted therapeutic strategies.展开更多
Background:Previous researches mainly focused on whether cancer stem cells exist in diffuse large B-cell lym-phoma(DLBCL).However,subgroups with dismal prognosis and stem cell-like characteristics have been over-looke...Background:Previous researches mainly focused on whether cancer stem cells exist in diffuse large B-cell lym-phoma(DLBCL).However,subgroups with dismal prognosis and stem cell-like characteristics have been over-looked.Methods:Using large scale data(n=2133),we conducted machine learning algorithms to identify a high risk DLBCL subgroup with stem cell-like features,and then investigated the potential mechanisms in shaping this subgroup using transcriptome,genome and single-cell RNA-seq data,and in vitro experiments.Results:We identified a high-risk subgroup(25.6%of DLBCL)with stem cell-like characteristics and dismal prog-nosis.This high-risk group(HRG)was featured by upregulation of key enzyme(ODC1)in polyamine metabolism and cold tumor microenvironment(TME),and had a poor prognosis with lower 3-year overall survival(OS)(54.3%vs.83.6%,P<0.0001)and progression-free survival(PFS)(42.8%vs.74.7%,P<0.0001)rates com-pared to the low-risk group.HRG also exhibited malignant proliferative phenotypes similar to Burkitt lymphoma.Patients with MYC rearrangement,double-hit,double-expressors,or complete remission might have either favor-able or poor prognosis,which could be further distinguished by our risk stratification model.Genomic analysis revealed widespread copy number losses in the chemokine and interferon coding regions 8p23.1 and 9p21.3 in HRG.We identified ODC1 as a therapeutic vulnerability for HRG-DLBCL.Single-cell analysis and in vitro ex-periments demonstrated that ODC1 overexpression enhanced DLBCL cell proliferation and drove macrophage polarization towards the M2 phenotype.Conversely,ODC1 inhibition reduced DLBCL cell proliferation,induced cell cycle arrest and apoptosis,and promoted macrophage polarization towards the M1 phenotype.Finally,we developed a comprehensive database of DLBCL for clinical application.Conclusions:Our study effectively advances the precise risk stratification of DLBCL and reveals that ODC1 and immune-deserted microenvironment jointly shape a group of DLBCL patients with stem cell-like features.Target-ing ODC1 regulates immunotherapies in DLBCL,offering new insights for DLBCL treatment.展开更多
Computed tomography-based deep learning radiomics provides a novel,noninvasive approach to predicting the tumor immune microenvironment in colorectal cancer,revolutionizing precision oncology.The retrospective study b...Computed tomography-based deep learning radiomics provides a novel,noninvasive approach to predicting the tumor immune microenvironment in colorectal cancer,revolutionizing precision oncology.The retrospective study by Zhou et al analyzed preoperative computed tomography scans from 315 patients using convolutional neural networks,achieving robust predictive performance(area under the curve:0.851-0.892)for critical tumor immune microenvironment features,such as tumor-stroma ratio and lymphocyte infiltration,without requiring invasive biopsies.This editorial explores how this technique advances personalized immunotherapy,chemotherapy,and targeted therapies;challenges conventional oncology practices;and paves the way for a future of precision medicine.By integrating advanced imaging with immune profiling,deep learning radiomics redefines colorectal cancer management,highlighting the need to reevaluate the interplay of technology,biology,and ethics in gastrointestinal oncology.展开更多
基金supported by the National Natural Science Foundation of China(Nos.82302373,81903846)Natural Science Foundation of Sichuan Province(No.2022NSFSC1925)+1 种基金Chengdu Technology Innovation Research and Development Project(No.2022-YF05-01546-SN)the Introduction of Talents Research Project of Chengdu University(No.2081921049)。
文摘Emerging ferroptosis-immunotherapy strategies,integrating functionalized nanoplatforms with ferroptosis-inducing agents and immunomodulatory therapeutics,demonstrate significant potential in managing primary,recurrent,and metastatic malignancies.Mechanistically,ferroptosis induction not only directly eliminates tumor cells but also promotes immunogenic cell death(ICD),eliciting damage-associated molecular patterns(DAMPs)release to activate partial antitumor immunity.However,standalone ferroptosis therapy fails to initiate robust systemic antitumor immune responses due to inherent limitations:low tumor immunogenicity,immunosuppressive microenvironment constraints,and tumor microenvironment(TME)-associated physiological barriers(e.g.,hypoxia,dense extracellular matrix).To address these challenges,synergistic approaches have been developed to enhance immune cell infiltration and reestablish immunosurveillance,encompassing(1)direct amplification of antitumor immunity,(2)disruption of immunosuppressive tumor niches,and(3)biophysical hallmark remodeling in TME.Rational nanocarrier design has emerged as a critical enabler for overcoming biological delivery barriers and optimizing therapeutic efficacy.Unlike prior studies solely addressing ferroptosis or nanotechnology in tumor therapy,this work first systematically outlines the synergistic potential of nanoparticles in combined ferroptosis-immunotherapy strategies.It advances multidimensional nanoplatform design principles for material selection,structural configuration,physicochemical modulation,multifunctional integration,and artificial intelligence-enabled design,providing a scientific basis for efficacy optimization.Moreover,it examines translational challenges of ferroptosis-immunotherapy nanoplatforms across preclinical and clinical stages,proposing actionable solutions while envisioning future onco-immunotherapy directions.Collectively,it provides systematic insights into advanced nanomaterial design principles and therapeutic optimization strategies,offering a roadmap for accelerating clinical translation in onco-immunotherapy research.
文摘Colorectal cancer remains one of the leading causes of morbidity and mortality worldwide.Despite notable advances in early detection and therapeutic strategies,the molecular mechanisms underlying tumor survival,chemotherapy resistance,and metastasis are not yet fully understood.MicroRNAs(miRNAs)have emerged as pivotal regulators of cancer development,as they modulate gene expression and orchestrate key signaling pathways.However,the epigenetic mechanisms that control miRNA expression and their downstream gene targets remain largely unclear.In this review,we highlight the critical role of the colorectal cancer microenvironment in influencing miRNA expression and discuss how this regulation contributes to tumorigenesis.A better understanding of these processes may lead to the identification of novel therapeutic targets and strategies to prevent recurrence.
基金Supported by National Natural Science Foundation of China,No.82170638Natural Science Foundation of the Science and Technology Commission of Shanghai Municipality,No.23ZR1458300+1 种基金Key Discipline Project of Shanghai Municipal Health System,No.2024ZDXK0004and Pujiang Project of Shanghai Magnolia Talent Plan,No.24PJD098.
文摘Colorectal cancer(CRC)is ranked as the third most common tumor globally,representing approximately 10%of all cancer cases,and is the second primary cause of cancer-associated mortality.Existing therapeutic approaches demonstrate limited efficacy against CRC,partially due to the immunosuppressive tumor microenvironment(TME).In recent years,substantial evidence indicates that dysbiosis of the gut microbiota and its metabolic products is closely associated with the initiation,progression,and prognostic outcomes of CRC.In this minireview,we systematically elaborate on how these microbes and their metabolites directly impair intestinal epithelial integrity,activate cancer-associated fibroblasts,remodel tumor vasculature,and critically,sculpt an immunosuppressive landscape by modulating T cells,dendritic cells,and tumor-associated macrophages.We highlight the translational potential of targeting the gut microbiota,including fecal microbiota transplantation,probiotics,and engineered microbial systems,to reprogram the TME and overcome resistance to immunotherapy and chemotherapy.A deeper understanding of the microbiota-TME axis is essential for developing novel diagnostic and therapeutic paradigms for CRC.
基金Supported by the Shanghai Science and Technology Commission Project,No.21010504300Shanghai Jiading District Traditional Chinese Medicine Key Specialty Construction Project,No.2020-JDZYYZDZK-01.
文摘BACKGROUND In recent years,numerous reports have been published regarding the relationship between the gut microbiota and the tumor immune microenvironment(TIME).However,to date,no systematic study has been conducted on the relationship between gut microbiota and the TIME using bibliometric methods.AIM To describe the current global research status on the correlation between gut microbiota and the TIME,and to identify the most influential countries,research institutions,researchers,and research hotspots related to this topic.METHODS We searched for all literature related to gut microbiota and TIME published from January 1,2014,to May 28,2024,in the Web of Science Core Collection database.We then conducted a bibliometric analysis and created visual maps of the published literature on countries,institutions,authors,keywords,references,etc.,using CiteSpace(6.2R6),VOSviewer(1.6.20),and bibliometrics(based on R 4.3.2).RESULTS In total,491 documents were included,with a rapid increase in the number of publications starting in 2019.The country with the highest number of publications was China,followed by the United States.Germany has the highest number of citations in literature.From a centrality perspective,the United States has the highest influence in this field.The institutions with the highest number of publications were Shanghai Jiao Tong University and Zhejiang University.However,the institution with the most citations was the United States National Cancer Institute.Among authors,Professor Giorgio Trinchieri from the National Institutes of Health has the most local impact in this field.The most cited author was Fan XZ.The results of journal publications showed that the top three journals with the highest number of published papers were Frontiers in Immunology,Cancers,and Frontiers in Oncology.The three most frequently used keywords were gut microbiota,tumor microenvironment,and immunotherapy.CONCLUSION This study systematically elaborates on the research progress related to gut microbiota and TIME over the past decade.Research results indicate that the number of publications has rapidly increased since 2019,with research hotspots including“gut microbiota”,“tumor microenvironment”and“immunotherapy”.Exploring the effects of specific gut microbiota or derived metabolites on the behavior of immune cells in the TIME,regulating the secretion of immune molecules,and influencing immunotherapy are research hotspots and future research directions.
基金supported by the Natural Science Foundation of Hunan Province(No.2021JJ30589)Hunan Provincial Natural Science Foundation Sector Joint Fund(No.2023JJ60049).
文摘Approximately half of all cancers have p53 inactivating mutations,in addition to which most malignancies inactivate the p53 pathway by increasing p53 inhibitors,decreasing p53 activators,or inactivating p53 downstream targets.A growing number of researches have demonstrated that p53 can influence tumor progression through the tumor microenvironment(TME).TME is involved in the process of tumor development and metastasis and affects the clinical prognosis of patients.p53 participates in host immunity and engages in the immune landscape of the TME,but the specific mechanisms remain to be investigated.This review briefly explores the interactions between different states of p53 and TME components and their mechanisms,as well as their effects on tumor progression.To understand the progress of drug development and clinical studies related to p53 and tumor microenvironment.
基金supported by the Natural Science Foundation of Liaoning Province(2023-MSBA-020)the Fundamental Research Funds for Central Universities(DUT24MS020)Science and Technology Innovation Fund of Dalian(2022JJ13SN073).
文摘Ferroptosis is a novel form of cell death driven by oxidative damage,and is implicated in various pathological conditions,including neurodegenerative diseases,retinal damage,and ischemia-reperfusion injury of organs.Inhibiting ferroptosis has shown great promise as a therapeutic strategy for these diseases,underscoring the urgent need to develop effective ferroptosis inhibitors.Although Ferrostatin-1(Fer-1)is a potent ferroptosis inhibitor,its susceptibility to oxidation and metabolic inactivation limits its clinical utility.In this study,the accumulation of peroxides and the resulting oxidative damage in the cellular microenvironment during ferroptosis were utilized to design Ferrostatin-1 prodrugs with reactive oxygen species-responsive features.This approach led to the development of a series of ferroptosis inhibitors that were capable of recognizing oxidative damage in diseased areas,allowing for targeted release and improved stability.The novel compounds demonstrated significant inhibitory effects and selectivity against RSL-3-induced ferroptosis in HK-2 cells,with compound a1 exhibiting an EC50 of 15.4�0.7μM,outperforming Fer-1.These compounds effectively identify the oxidative microenvironment associated with ferroptosis,enabling the targeted release of Fer-1,which prevents lipid peroxide accumulation and inhibits ferroptosis.This strategy holds promise for treating diseases related to ferroptosis,offering a targeted and intelligent therapeutic approach.
基金supported by the NIH/NCI grants(No.P01CA257907)the Educational Department of Hunan Province for Excellent Youth Scholars(No.23B0011)。
文摘In the past decade,immunotherapies targeting cytotoxic T-lymphocyte antigen-4(CTLA-4),programmed cell death 1(PD-1),and PD-1 ligand(PD-L1)have been approved for solid tumors.However,some patients demonstrate suboptimal clinical outcomes due to resistance.The tumor microenvironment(TME)significantly affects the efficiency of immunotherapy by mediating interactions between tumor and non-tumor cells,including dendritic cells,T cells,B cells,macrophages,neutrophils,NK cells,and myeloid-derived suppressor cells(MDSCs).These non-tumor cells often exhibit two phenotypes with altered functions,and tumor cells drives their transition towards tumor promotion through tumor-education.Tumor-educated cells(TECs)are cells influenced by tumor cells,which acquire immune-suppressive phenotypes and promote tumor progression through resistance to anticancer therapies.These cells undergo modifications in response to signals from the tumor,which can influence their roles in tumor progression.Their dynamic interactions with tumor cells contribute to the reshaping of the TME,facilitating cancer growth and immune modulation.This review summarizes research on TECs in TME,explores mechanisms related to tumor education,and discusses their role in tumor progression and immunotherapy resistance.Additionally,potential therapeutic approaches targeting these cells are also reviewed,which may complement current treatment strategies.
基金supported by Guangdong Basic and Applied Basic Research Foundation(2024A1515012993)the Project of Hunan Provincial Health Commission(No.D202303078877).
文摘Hepatocellular carcinoma(HCC)is a highly aggressive malignancy,largely driven by an immunosuppres-sive tumor microenvironment(TME)that facilitates tumor growth,immune escape,and resistance to therapy.Although immunotherapy—particularly immune checkpoint inhibitors(ICIs)—has transformed the therapeutic landscape by restoring T cell-mediated anti-tumor responses,their clinical benefit as monotherapy remains suboptimal.This limitation is primarily attributed to immunosuppressive components within the TME,including tumor-associated macrophages,regulatory T cells(Tregs),and myeloid-derived suppressor cells(MDSCs).To address these challenges,combination strategies have been explored,such as dual checkpoint blockade targeting programmed cell death protein 1(PD-1),programmed death-ligand 1(PD-L1),and cytotoxic T-lymphocyte-associated antigen 4(CTLA-4),as well as synergistic use of ICIs with anti-angiogenic agents or TME-targeted interventions.These approaches have shown encouraging potential in enhancing immune efficacy.This review outlines the complex crosstalk between the TME and immunotherapeutic responses in HCC,emphasizing how combination regimens may overcome immune resistance.Furthermore,we discuss the remaining hurdles,including therapeutic resistance and immune-related adverse events,and propose future directions involving TME-associated biomarkers and individualized treatment strategies to improve patient outcomes.
文摘In this article,we comment on the work published by Huang et al,which explores the mechanisms by which Calculus bovis(CB)modulates the liver cancer immune microenvironment via the Wnt/β-catenin signalling pathway.The study demon-strates that active components in CB effectively inhibit the activation of the Wnt/β-catenin pathway,significantly reducing the polarization of M2 tumor-associated macrophages.Both in vivo and in vitro experiments have validated the anti-tumour effects of CB,revealing its complex mechanisms of action through the modulation of immune cell functions within the tumour microenvironment.This article highlights CB’s therapeutic potential in liver cancer treatment and calls for further investigations into its mechanisms and clinical applications to develop safer,more effective options for patients.The study also revealed that key com-ponents of CB,such as bilirubin and bile acids,inhibit tumour cell proliferation and promote apoptosis through multiple pathways.Future research should explore the mechanisms of action of CB and its potential integration with existing treatments to improve the therapeutic outcomes of liver cancer patients.With multidisciplinary collaboration and advanced research,CB could become a key component of comprehensive liver cancer treatment,offering new hope for patients.
文摘Colorectal cancer(CRC)considerably affects global health,and its progression is intricately tied to interactions within the tumormicroenvironment.This review focuses on the intricate crosstalk between metabolic reprogramming in CRC cells and the tumor immune microenvironment(TIME),thereby emphasizing the dual functionality of metabolic pathways in tumor growth and immune regulation.Furthermore,the review delves into key metabolic changes,including alterations in glucose,lipid,iron,and ammonia metabolism,and their profound effects on the immune landscape of CRC.Enhanced glycolysis and lipid metabolism facilitate tumor survival and proliferation,while establishing an immunosuppressive TIME that hinders effective immune responses.Moreover,the roles of iron and ammonia metabolism in immune evasion and tumor progression were explored,and these metabolic pathways presented as promising targets to improve CRC therapy.By conducting a comprehensive analysis of recent studies,this review provides insights into potential therapeutic targets within these metabolic interactions,with the aim of enhancing the efficacy of existing treatments and devising novel strategies for combating CRC.
基金financially supported by the Key Research and Development Program of Hubei Province(No.2022BCA082 and No.2022BEC013).
文摘The presence of impurities in phosphogypsum has long impeded its effective utilization,highlighting the need for energy-efficient and sustainable purification methods.This study proposes a novel purification strategy that synergistically combines pH regulation and micelle-assisted treatment to create an optimized microenvironment for impurity removal.Under mechanical grinding conditions,this approach enhances the rheological properties of the phosphogypsumslurries and facilitates the dissolution and removal of impurity ions.Experimental results demonstrate that the synergistic method achieves a remarkable 64.01%increase in whiteness while significantly reducing soluble phosphorus and fluoride content in a single-step process.This technique not only achieves high purification efficiency but also offers a practical pathway for the high-value utilization of phosphogypsum.These findings suggest that this method has substantial potential for enhancing sustainable resource management and enabling broader industrial applications of purified phosphogypsum.
基金partially supported by grants from the Non-communicable Chronic Diseases-National Science and Technology Major Project(grant num-ber:2023ZD0510300)the National Natural Science Foundation of China(grant numbers:82403377,82473192).
文摘The landscape of tumor microenvironment(TME)research has un-dergone rapid transformation over the past decade.1,2 As we deepen our understanding of the TME’s role in cancer progression,immune response modulation,and therapeutic efficacy,this special issue,“Tumor Microen-vironment and Immunotherapy:From Bench to Bedside,”brings forth the latest breakthroughs in these domains.It highlights the interplay be-tween the TME,immune system dynamics,and cancer therapies,with a particular emphasis on precision medicine and the development of targeted treatments.
基金supported by the National Natural Science Foundation of China(Nos.22078201,U1908202)Liaoning&Shenyang Key Laboratory of Functional Dye and Pigment(Nos.2021JH13/10200018,21-104-0-23,LJKZ0453)China Medical University’s High-Quality Development Science and Technology Funding Program(Nos.2022JH2/20200063,2023JH2/20200162).
文摘Therapy-induced modulation of the tumor microenvironment(TME)to overcome the immunosuppressive TME is considered to be a chance for cancer treatment.Herein,we prepared near-infrared absorbing aza-BODIPY PhEt-azaBDP with 1-phenylethyl group at 1,7-sites,a type I photodynamic-photothermal therapy(PDT-PTT)agent.Self-assembly PhEt-azaBDP nanoparticles(NPs)can provide combined phototherapeutic effects under light irradiation and simultaneously induce inflammatory TME,by monitoring tumorassociated macrophages(TAMs)repolarization.Utilizing cluster of differentiation 86(CD86)and CD163 as the M1-type marker and M2-type marker respectively,PhEt-azaBDP NPs resulted in the increasement of the expression of CD86 and the decreasement of the expression of CD163 in TAMs under near-infrared(NIR)light irradiation,promoting TAMs to switch from M2-phenotype to M1-phenotype.Inflammatory cytokines,interleukin-1β(IL-1β)and tumor necrosis factor-α(TNF-α),could be the key cytokine involved in the phototherapy-induced TME reprogramming.PhEt-azaBDP NPs could be a potential theranostic scaffold for the simultaneous induction and detection of TME reprogramming triggered by phototherapy.
基金supported by the National Natural Science Foundation of China(22393961,U23A20132,22209007)the Beijing Natural Science Foundation(2232016)+1 种基金the Beijing Nova Program(20240484611)the Fundamental Research Funds for the Central Universities,China(buctrc202029,buctrc202129).
文摘Electrocatalytic CO_(2)reduction(CO_(2)RR)is spurring intensive research interest,where many attentions have been paid to catalyst design and mechanism study.Electrode near-surface microenvironment matters fundamentally for reactant mass transfer,water molecule interference,catalyst exposure,and others,yet it has been rarely investigated.In the latest issue of Angew.Chem.Int.Ed.,Han,Kang and coauthors reported a method to regulate the microenvironment on the catalyst surface by adding polyethylene glycol,which remarkably improves the yield of multicarbon products.This strategy of controlling multiple proton-electron coupling processes through molecular chemistry-driven microenvironmental regulation is thought to inspire new idea for addressing the low efficiency challenge of CO_(2)RR.
基金the financial support by National Natural Science Foundation of China(No.82171997)the Guangdong Basic and Applied Basic Research Fund Foundation(No.2023B1515120073)+2 种基金the Science and Technology Planning Project of Guangdong Province(No.2023B1212060013)Guangzhou Science and Technology Bureau(No.2023A03J0708)Shenzhen Science and Technology Program(Nos.JCYJ20230807111120043,JCYJ20220818102014028)。
文摘Sorafenib(Sora)not only has an inhibitory effect on angiogenesis via indirectly inhibiting tumor growth through antiangiogenesis,but also can inactivate the glutathione peroxidase 4(GPX4)to induce ferroptosis.Nonetheless,the therapeutic efficacy is hampered by a plethora of factors,including low bioavailability and tumor microenvironment(TME).Of particular note is the hypoxic and reductive TME,which acts as a significant impediment and poses formidable challenges to attain the most optimal treatment outcomes.Herein,we developed a novel therapeutic platform based on Sora-loaded mesoporous ferromanganese nanoparticles(PMFNs@Sora).PMFNs mimics both catalase and GPX activities.The self-sustained catalase activity enables continuous decomposition of hydrogen peroxide to generate oxygen,which alleviates hypoxia microenvironment.The GPX activity simultaneously amplifies the therapeutic efficacy of Sora.The as-synthesized PMFNs@Sora demonstrates significantly enhanced antitumor effect in vitro through apoptosis-ferroptosis,revealed by Western blot.Furthermore,PMFNs@Sora also showed effective tumor growth inhibition in vivo.This multifunctional nanoplatform offers a promising strategy for modulating the TME and enhancing cancer treatment in clinical application.
基金funded by grants from the National Natural Science Foundation of China(Grant Nos.82373263 and 82403835)the National Key Research and Development Program of China(Grant No.2023YFC2506400)+2 种基金China Postdoctoral Science Foundation(Grant No.2024M751405)Jiangsu Provincial Natural Science Foundation Youth Project(Grant No.BK20240247)General Project of Nanjing Health Science and Technology Development Program(Grant No.YKK24084).
文摘Tumor-associated neutrophils(TANs)exhibit highly func-tional heterogeneity across cancers.Although TANs pro-mote inflammatory responses and contribute to tumor clearance,they frequently undergo context-dependent reprogramming within the tumor microenvironment(TME)into highly immunosuppressive phenotypes that facilitate cancer dissemination and immunotherapy resist-ance1,2.We contend that an underappreciated,upstream determinant of this divergence is the maturation stage of TANs3,4.The developmental stage of TANs determines the migration patterns and constrains the functional capacity,and the developmental stage also constrains the extent of TME-driven re-education,together shaping pro-or anti-tu-mor outcomes3-5.In this Perspective,we place maturation at the core of TAN biology and discuss current definitions for TAN developmental stages and the measurable mark-ers that researchers and clinicians can use(Figure 1).In addition,spatial and temporal transitions in TAN matu-ration stages and the factors that govern these transitions are elucidated.We explain how maturation status shapes TAN function and articulate the key differences between mouse and human TAN maturation systems to highlight the value of human immune system(HIS)mouse models.Based on this framework,functional biomarkers and signa-tures of TAN maturation are introduced and we show how to embed them into patient stratification and longitudinal monitoring.Finally,we outline immunotherapy strategies targeting TAN maturation,selecting interventions guided by maturation markers to reinforce treatment benefits for cancer patients.
基金supported by the National Science Foundation of China(82202714).
文摘Severe tissue defects present formidable challenges to human health,persisting as major contributors to mortality rates.The complex pathological microenvironment,particularly the disrupted immune landscape within these defects,poses substantial hurdles to existing tissue regeneration strategies.However,the emergence of nanobiotechnology has opened a new direction in immunomodulatory nanomedicine,providing encouraging prospects for tissue regeneration and restoration.This review aims to gather recent advances in immunomodulatory nanomedicine to foster tissue regeneration.We begin by elucidating the distinctive features of the local immune microenvironment within defective tissues and its crucial role in tissue regeneration.Subsequently,we explore the design and functional properties of immunomodulatory nanosystems.Finally,we address the challenges and prospects of clinical translation in nanomedicine development,aiming to propose a potent approach to enhance tissue regeneration through synergistic immune modulation and nanomedicine integration.
基金funded by the Top Talent Support Program for Young and Middle-aged People of Wuxi Health Commission(No.BJ2023014)the General Program of Wuxi Medical Center of Nanjing Medical University(No.WMCG202406)the Quality Talent Program of Wuxi Medical Center of Nanjing Medical University(No.WMCQ202401)。
文摘Objective:A highly aggressive and lethal malignancy,characterized by its heterogeneity,lung adenocarcinoma(LUAD)presents significant challenges in prognosis and treatment.Disulfidptosis,a newly identified form of regulated cell death,offers novel insights into cancer progression,yet its role in LUAD remains poorly understood.Methods:We identified disulfidptosis-related genes(DRGs)from prior studies and analyzed their interactions and functional enrichment.Molecular subtypes were identified through consensus clustering based on DRG expression,and a prognostic DRG signature was developed using multivariate Cox regression analysis.A nomogram integrating clinical variables was developed to predict survival.Comprehensive analyses,including single-cell RNA sequencing,immune infiltration,and drug sensitivity,were validated using clinical specimens,LUAD cell lines,Western blotting(WB)and immunohistochemistry(IHC).Results:A total of 16 DRGs were identified,classifying LUAD patients into three distinct subtypes with differential survival and immune profiles.A 4-gene signature(GYS1,NDUFA11,NDUFB10,SLC7A11)was used to build a risk score model,demonstrating robust prognostic accuracy.A nomogram combining this signature with clinical features reliably predicted 1-,3-,and 5-year survival.The signature correlated with immune cell infiltration,with single-cell analysis revealing DRG enrichment in myeloid cells.Notably,SLC7A11 and GYS1 were positively associated with chemotherapeutic drug sensitivity.Validation through reverse transcription quantitative polymerase chain reaction(RT-qPCR),WB and IHC confirmed upregulated DRG expression in LUAD tissues and cell lines.Conclusions:This research highlights the essential role of DRGs in modulating the tumor microenvironment,influencing therapeutic response,and determining the prognosis of LUAD.The risk model and nomogram,derived from DRG expression,offer robust tools for survival prediction and personalized treatment stratification,facilitating the development of disulfidptosis-targeted therapeutic strategies.
基金supported by grants from the National Natural Science Foundation of China(grant number:82170181)Beijing Natural Science Foundation(grant number:7222027)+4 种基金Beijing Physician Scientist Train-ing Project(grant number:BJPSTP-2024-01)the National Key R&D Program of China(grant number:2022YFF1502000)to Liang Wangthe National Key R&D Program of China(grant number:2022YFF1502000)Beijing Municipal Fund for Distinguished Young Scholars(grant number:JQ22022)to Lin FengHebei province government funding for clinical medical talents training and basic research projects(grant number:361007)to Youchao Jia.
文摘Background:Previous researches mainly focused on whether cancer stem cells exist in diffuse large B-cell lym-phoma(DLBCL).However,subgroups with dismal prognosis and stem cell-like characteristics have been over-looked.Methods:Using large scale data(n=2133),we conducted machine learning algorithms to identify a high risk DLBCL subgroup with stem cell-like features,and then investigated the potential mechanisms in shaping this subgroup using transcriptome,genome and single-cell RNA-seq data,and in vitro experiments.Results:We identified a high-risk subgroup(25.6%of DLBCL)with stem cell-like characteristics and dismal prog-nosis.This high-risk group(HRG)was featured by upregulation of key enzyme(ODC1)in polyamine metabolism and cold tumor microenvironment(TME),and had a poor prognosis with lower 3-year overall survival(OS)(54.3%vs.83.6%,P<0.0001)and progression-free survival(PFS)(42.8%vs.74.7%,P<0.0001)rates com-pared to the low-risk group.HRG also exhibited malignant proliferative phenotypes similar to Burkitt lymphoma.Patients with MYC rearrangement,double-hit,double-expressors,or complete remission might have either favor-able or poor prognosis,which could be further distinguished by our risk stratification model.Genomic analysis revealed widespread copy number losses in the chemokine and interferon coding regions 8p23.1 and 9p21.3 in HRG.We identified ODC1 as a therapeutic vulnerability for HRG-DLBCL.Single-cell analysis and in vitro ex-periments demonstrated that ODC1 overexpression enhanced DLBCL cell proliferation and drove macrophage polarization towards the M2 phenotype.Conversely,ODC1 inhibition reduced DLBCL cell proliferation,induced cell cycle arrest and apoptosis,and promoted macrophage polarization towards the M1 phenotype.Finally,we developed a comprehensive database of DLBCL for clinical application.Conclusions:Our study effectively advances the precise risk stratification of DLBCL and reveals that ODC1 and immune-deserted microenvironment jointly shape a group of DLBCL patients with stem cell-like features.Target-ing ODC1 regulates immunotherapies in DLBCL,offering new insights for DLBCL treatment.
文摘Computed tomography-based deep learning radiomics provides a novel,noninvasive approach to predicting the tumor immune microenvironment in colorectal cancer,revolutionizing precision oncology.The retrospective study by Zhou et al analyzed preoperative computed tomography scans from 315 patients using convolutional neural networks,achieving robust predictive performance(area under the curve:0.851-0.892)for critical tumor immune microenvironment features,such as tumor-stroma ratio and lymphocyte infiltration,without requiring invasive biopsies.This editorial explores how this technique advances personalized immunotherapy,chemotherapy,and targeted therapies;challenges conventional oncology practices;and paves the way for a future of precision medicine.By integrating advanced imaging with immune profiling,deep learning radiomics redefines colorectal cancer management,highlighting the need to reevaluate the interplay of technology,biology,and ethics in gastrointestinal oncology.
